| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. (FULC) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. FULC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.08M | $26.70M | +417.6K | |
| 10% | 6.05M | $22.82M | - | |
| Dir | 469.9K | $1.77M | - | |
| Other | 10.3K | $38.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2021 | Thomson Peter G. | VP Finance &Accounting | Sell | 6,607 | $14.00 | $92,498.00 | -30.3% | |
| Jan 20, 2021 | Gould Robert J85 | See Remarks | Sell | 10,000 | $12.08 | $120,826.00 | -1.9% | |
| Jul 8, 2020 | Wallace Owen B. | Chief Scientific Officer | Sale+OE | 2,951 | $20.00 | $59,020.00 | -2.3% | |
| Jul 8, 2020 | Gould Robert J85 | See Remarks | Sell | 2,500 | $20.00 | $50,000.00 | -0.5% | |
| Jul 1, 2020 | Cadavid Diego | SVP Clinical Development | Sell | 1,071 | $18.30 | $19,599.30 | -1.6% | |
| Jun 30, 2020 | Wallace Owen B. | Chief Scientific Officer | Sale+OE | 141 | $20.00 | $2,820.00 | -0.1% | |
| Jun 25, 2020 | Cadavid Diego | SVP Clinical Development | Sale+OE | 1,459 | $22.00 | $32,098.00 | -2.1% | |
| Jun 25, 2020 | Gould Robert J85 | See Remarks | Sell | 2,500 | $20.80 | $51,992.00 | -0.5% | |
| Jun 10, 2020 | Cadavid Diego | SVP Clinical Development | Sale+OE | 401 | $22.00 | $8,822.00 | -0.6% | |
| Jun 9, 2020 | Gould Robert J85 | See Remarks | Sell | 156 | $20.00 | $3,120.00 | - |